Vaccinia Virus Live Antigen

Vaccinia Virus Live Antigen Uses, Dosage, Side Effects, Food Interaction and all others data.

The New York City Board of Health strain of Vaccinia is a viral strain used as a component of some smallpox vaccinations. ACAM2000, a percutaneously administered smallpox vaccine that was approved by the FDA in 2007, contains live antigens of this strain.

Vaccinia Virus Live Antigen
Uses
Dosage
Side Effect
Precautions
Interactions
Uses during Pregnancy
Uses during Breastfeeding
Accute Overdose
Food Interaction
Half Life
Volume of Distribution
Clearance
Interaction With other Medicine
Contradiction
Storage

Trade Name	Vaccinia Virus Live Antigen
Generic	Smallpox (Vaccinia) Vaccine, Live
Smallpox (Vaccinia) Vaccine, Live Other Names	Smallpox (vaccinia) vaccine, live, Smallpox vaccine, Vaccinia virus live antigen, B, Vaccinia virus strain new york city board of health live (attenuated) antigen, Vaccinia virus strain new york city board of health live antigen, Vaccininum, Vaccinotoxinum
Type
Groups	Approved
Therapeutic Class
Manufacturer
Available Country
Last Updated:	September 19, 2023 at 7:00 am

Uses

The live antigen of the New York City Board of Health strain of Vaccinia is indicated (within the ACAM2000 formulation) for active immunization against smallpox disease in patients determined to be at high risk of contracting smallpox infection.

Vaccinia Virus Live Antigen is also used to associated treatment for these conditions: Smallpox